DISCOUNT ZERTIFIKAT - CELSIUS HLDGS Share Price

Certificat

DE000ME7E3V0

Real-time Bid/Ask 13:57:02 27/06/2024 BST
34.13 EUR / 34.27 EUR -0.06% Intraday chart for DISCOUNT ZERTIFIKAT - CELSIUS HLDGS
Current month-3.14%
1 month-4.01%
Date Price Change
27/06/24 33.93 -0.85%
26/06/24 34.22 +0.38%
25/06/24 34.09 -1.90%
24/06/24 34.75 -0.09%
21/06/24 34.78 +0.58%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 11:45 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME7E3V
ISINDE000ME7E3V0
Date issued 23/01/2024
Cap 40 $
Last trading day 20/12/2024
Maturity 20/12/2024 (176 Days)
Parity 1 : 1
Emission price 31.2
Emission volume N/A
Payment day 31/12/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 34.77 %
Sideways yield 9.014 %
Sideways yield pa 18.69 %
Outperformance point 61.32 $
Break even 36.69 €
Highest since issue 35.75
Lowest since issue 30.59
Spread 0.41
Spread %1.19%
Distance Cap 16.56 $
Distance Cap %+29.28%
Max. earning 3.086
Max. earning % 9.014 %

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
56.56 USD
Average target price
83.43 USD
Spread / Average Target
+47.51%
Consensus